{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:37:00Z","timestamp":1792449420671,"version":"4.5.0"},"reference-count":152,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.intimp.2025.114185","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T03:43:58Z","timestamp":1738381438000},"page":"114185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Advances in the Pathogenesis and Treatment Strategies for Type 1 Diabetes Mellitus"],"prefix":"10.1016","volume":"148","author":[{"given":"Meiheng","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jufang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.114185_b0005","first-page":"141","article-title":"Pancreatic extracts in the treatment of diabetes mellitus","volume":"12","author":"Banting","year":"1922","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.intimp.2025.114185_b0010","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/1573396318666220409001955","article-title":"Biology and natural history of type 1 diabetes mellitus","volume":"19","author":"de Azevedo","year":"2023","journal-title":"Curr. Pediatr. Rev."},{"key":"10.1016\/j.intimp.2025.114185_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.933965","article-title":"Environmental triggering of type 1 diabetes autoimmunity","volume":"13","author":"Houeiss","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.intimp.2025.114185_b0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010480","article-title":"The role of the gut microbiota in the pathogenesis of diabetes","volume":"23","author":"Bielka","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.114185_b0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010344","article-title":"Applications of genome-editing technologies for type 1 diabetes","volume":"25","author":"El Nahas","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.114185_b0030","doi-asserted-by":"crossref","first-page":"Itc33","DOI":"10.7326\/AITC202203150","article-title":"Type 1 diabetes mellitus","volume":"175","author":"Syed","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.intimp.2025.114185_b0035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12933-023-02117-7","article-title":"Type 1 diabetes, its complications, and non-ischemic cardiomyopathy: a Mendelian randomization study of European ancestry","volume":"23","author":"Zhao","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.intimp.2025.114185_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106792","article-title":"Lessons and gaps in the prediction and prevention of type 1 diabetes","volume":"193","author":"Mameli","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2025.114185_b0045","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.16","article-title":"Type 1 diabetes mellitus","volume":"3","author":"Katsarou","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.intimp.2025.114185_b0050","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2796.2007.01896.x","article-title":"Gender differences and temporal variation in the incidence of type 1 diabetes: results of 8012 cases in the nationwide Diabetes Incidence Study in Sweden 1983-2002","volume":"263","author":"Ostman","year":"2008","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.intimp.2025.114185_b0055","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1503\/cmaj.060244","article-title":"Type 1 diabetes: pathogenesis and prevention","volume":"175","author":"Gillespie","year":"2006","journal-title":"CMAJ"},{"key":"10.1016\/j.intimp.2025.114185_b0060","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S2213-8587(22)00159-0","article-title":"Type 1 diabetes in diverse ancestries and the use of genetic risk scores","volume":"10","author":"Redondo","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.intimp.2025.114185_b0065","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/S0140-6736(16)30582-7","article-title":"Genetic risk factors for type 1 diabetes","volume":"387","author":"Pociot","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2025.114185_b0070","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/jama.2021.11165","article-title":"Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the US, 2001-2017","volume":"326","author":"Lawrence","year":"2021","journal-title":"JAMA - J. Am. Med. Assoc."},{"key":"10.1016\/j.intimp.2025.114185_b0075","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JME-13-0067","article-title":"Why is type 1 diabetes increasing?","volume":"51","author":"Egro","year":"2013","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.intimp.2025.114185_b0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4239\/wjd.v11.i1.13","article-title":"Current understandings of the pathogenesis of type 1 diabetes: genetics to environment","volume":"11","author":"Giwa","year":"2020","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.intimp.2025.114185_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.876470","article-title":"The etiology and pathogenesis of type 1 diabetes - a personal, non-systematic review of possible causes, and interventions","volume":"13","author":"Buschard","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.intimp.2025.114185_b0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4049\/jimmunol.2300660","article-title":"A targeted deep sequencing method to quantify endogenous retrovirus gag sequence variants and open reading frames expressed in nonobese diabetic mice","volume":"213","author":"Dai","year":"2024","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.114185_b0095","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ni0209-129","article-title":"Animal models of human type 1 diabetes","volume":"10","author":"von Herrath","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2025.114185_b0100","doi-asserted-by":"crossref","DOI":"10.1172\/JCI164460","article-title":"Type 1 diabetes: what is the role of autoimmunity in \u03b2 cell death?","volume":"132","author":"Donath","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2025.114185_b0105","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13287-017-0511-8","article-title":"CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success?","volume":"8","author":"Gerace","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.intimp.2025.114185_b0110","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1373\/clinchem.2010.148221","article-title":"Genetics of type 1 diabetes","volume":"57","author":"Steck","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.intimp.2025.114185_b0115","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1056\/NEJMc0805398","article-title":"Concordance for islet autoimmunity among monozygotic twins","volume":"359","author":"Redondo","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2025.114185_b0120","unstructured":"J. Lucier, R.S. Weinstock, \u201cType 1 Diabetes\u201d in StatPearls. (StatPearls Publishing) Copyright \u00a9 2024, StatPearls Publishing LLC., Treasure Island (FL), 2024."},{"key":"10.1016\/j.intimp.2025.114185_b0125","doi-asserted-by":"crossref","unstructured":"Anonymous, Variation and trends in incidence of childhood diabetes in Europe. EURODIAB ACE Study Group, Lancet 355 (2000) 873\u2013876.","DOI":"10.1016\/S0140-6736(99)07125-1"},{"key":"10.1016\/j.intimp.2025.114185_b0130","article-title":"Type 1 diabetes: global prevalence is set to double by 2040, study estimates","volume":"378","author":"Mahase","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.intimp.2025.114185_b0135","doi-asserted-by":"crossref","DOI":"10.3390\/nu11092185","article-title":"Influence of vitamin D on islet autoimmunity and beta-cell function in type 1 diabetes","volume":"11","author":"Infante","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2025.114185_b0140","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s00125-015-3820-4","article-title":"Insulitis and characterisation of infiltrating T cells in surgical pancreatic tail resections from patients at onset of type 1 diabetes","volume":"59","author":"Krogvold","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.intimp.2025.114185_b0145","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1126\/science.3086977","article-title":"Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans","volume":"232","author":"Bendtzen","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.intimp.2025.114185_b0150","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00429781","article-title":"The spontaneously diabetic Wistar rat (the \u201cBB\u201d rat)","volume":"14","author":"Nakhooda","year":"1978","journal-title":"Diabetologia"},{"key":"10.1016\/j.intimp.2025.114185_b0155","first-page":"380","article-title":"The non-obese diabetic (NOD) mouse","volume":"128","author":"Leiter","year":"1987","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2025.114185_b0160","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/icb.2015.89","article-title":"Perforin facilitates beta cell killing and regulates autoreactive CD8+ T-cell responses to antigen in mouse models of type 1 diabetes","volume":"94","author":"Trivedi","year":"2016","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.intimp.2025.114185_b0165","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.2337\/dc06-2389","article-title":"G. for the diabetes prevention trial\u2013type 1 study, role of insulin resistance in predicting progression to type 1 diabetes","volume":"30","author":"Xu","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.intimp.2025.114185_b0170","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/dmrr.1134","article-title":"A subset of human pancreatic beta cells express functional CD14 receptors: a signaling pathway for beta cell-related glycolipids, sulfatide and \u03b2-galactosylceramide","volume":"26","author":"Osterbye","year":"2010","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.intimp.2025.114185_b0175","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/abbs\/gmt092","article-title":"TLR4 is required for the obesity-induced pancreatic beta cell dysfunction","volume":"45","author":"Li","year":"2013","journal-title":"Acta Biochim. Biophy. Sin."},{"key":"10.1016\/j.intimp.2025.114185_b0180","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12020399","article-title":"Genetic and epigenetic aspects of type 1 diabetes mellitus: modern view on the problem","volume":"12","author":"Minniakhmetov","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2025.114185_b0185","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvad123","article-title":"A type 1 diabetes polygenic score is not associated with prevalent type 2 diabetes in large population studies","volume":"7","author":"Srinivasan","year":"2023","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.intimp.2025.114185_b0190","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.2337\/db10-0076","article-title":"Genetics of type 1 diabetes: what's next?","volume":"59","author":"Pociot","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2025.114185_b0195","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11892-019-1235-1","article-title":"The genetic contribution to type 1 diabetes","volume":"19","author":"Bakay","year":"2019","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.intimp.2025.114185_b0200","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/ng.3245","article-title":"Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers","volume":"47","author":"Onengut-Gumuscu","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.intimp.2025.114185_b0205","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ng0397-289","article-title":"Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus","volume":"15","author":"Vafiadis","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.intimp.2025.114185_b0210","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ng0397-293","article-title":"The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes","volume":"15","author":"Pugliese","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.intimp.2025.114185_b0215","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2017.12.008","article-title":"Identification of non-HLA genes associated with development of islet autoimmunity and type 1 diabetes in the prospective TEDDY cohort","volume":"89","author":"Sharma","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2025.114185_b0220","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1086\/429843","article-title":"Localization of a type 1 diabetes locus in the IL2RA\/CD25 region by use of tag single-nucleotide polymorphisms","volume":"76","author":"Vella","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.intimp.2025.114185_b0225","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.immuni.2010.04.001","article-title":"Etiology of type 1 diabetes","volume":"32","author":"Todd","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2025.114185_b0230","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/ng.3353","article-title":"Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk","volume":"47","author":"Hu","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.intimp.2025.114185_b0235","first-page":"269","article-title":"Type 1 diabetes: current concepts in epidemiology, pathophysiology, clinical care, and research","volume":"42","author":"Gan","year":"2012","journal-title":"Curr. Probl. Pediatr. Adolesc. Health Care"},{"key":"10.1016\/j.intimp.2025.114185_b0240","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.2337\/db20-0038","article-title":"Failed genetic protection: type 1 diabetes in the presence of HLA-DQB1*06:02","volume":"69","author":"Simmons","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2025.114185_b0245","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/pedi.12812","article-title":"Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children","volume":"20","author":"Jacobsen","year":"2019","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.intimp.2025.114185_b0250","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11892-011-0223-x","article-title":"Genetics of the HLA region in the prediction of type 1 diabetes","volume":"11","author":"Noble","year":"2011","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.intimp.2025.114185_b0255","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2337\/db18-0501","article-title":"Epitope stealing as a mechanism of dominant protection by HLA-DQ6 in type 1 diabetes","volume":"68","author":"van Lummel","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2025.114185_b0260","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2337\/db14-0858","article-title":"Proinsulin-specific, HLA-DQ8, and HLA-DQ8-transdimer\u2013restricted CD4+ T cells infiltrate islets in type 1 diabetes","volume":"64","author":"Pathiraja","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2025.114185_b0265","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.622647","article-title":"Proinsulin-reactive CD4 T cells in the islets of type 1 diabetes organ donors","volume":"12","author":"Landry","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.intimp.2025.114185_b0270","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00125-015-3514-y","article-title":"The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study","volume":"58","author":"Krischer","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.intimp.2025.114185_b0275","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.2337\/dc17-0238","article-title":"Genetic and environmental interactions modify the risk of diabetes-related autoimmunity by 6 years of age: the teddy study","volume":"40","author":"Krischer","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.intimp.2025.114185_b0280","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/dc19-0880","article-title":"Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes","volume":"43","author":"Battaglia","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.intimp.2025.114185_b0285","doi-asserted-by":"crossref","first-page":"e1510","DOI":"10.1210\/clinem\/dgab853","article-title":"Association of high-affinity autoantibodies with type 1 diabetes high-risk HLA haplotypes","volume":"107","author":"Triolo","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.intimp.2025.114185_b0290","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2337\/diab.33.2.176","article-title":"A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus","volume":"33","author":"Bell","year":"1984","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2025.114185_b0295","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ng2068","article-title":"Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes","volume":"39","author":"Todd","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.intimp.2025.114185_b0300","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/ng0395-284","article-title":"Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus","volume":"9","author":"Bennett","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.intimp.2025.114185_b0305","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ng1323","article-title":"A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes","volume":"36","author":"Bottini","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.intimp.2025.114185_b0310","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.2337\/diabetes.53.11.3020","article-title":"Replication of an association between the lymphoid tyrosine phosphatase locus (LYP\/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus","volume":"53","author":"Smyth","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2025.114185_b0315","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1111\/dme.14361","article-title":"Histological validation of a type 1 diabetes clinical diagnostic model for classification of diabetes","volume":"37","author":"Carr","year":"2020","journal-title":"Diabet. Med."},{"key":"10.1016\/j.intimp.2025.114185_b0320","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12916-017-0846-0","article-title":"Relative contribution of type 1 and type 2 diabetes loci to the genetic etiology of adult-onset, non-insulin-requiring autoimmune diabetes","volume":"15","author":"Mishra","year":"2017","journal-title":"BMC Med."},{"key":"10.1016\/j.intimp.2025.114185_b0325","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2337\/dc18-1785","article-title":"Development and standardization of an improved type 1 diabetes genetic risk score for use in newborn screening and incident diagnosis","volume":"42","author":"Sharp","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.intimp.2025.114185_b0330","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","article-title":"Regulation of mRNA translation and stability by microRNAs","volume":"79","author":"Fabian","year":"2010","journal-title":"Annu. Rev. Biochem"},{"key":"10.1016\/j.intimp.2025.114185_b0335","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1038\/s41598-020-60758-0","article-title":"Longitudinal DNA methylation differences precede type 1 diabetes","volume":"10","author":"Johnson","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2025.114185_b0340","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1038\/s41467-023-40632-z","article-title":"Reactivated endogenous retroviruses promote protein aggregate spreading","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.114185_b0345","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/eji.201646755","article-title":"Type 1 diabetes pathogenesis is modulated by spontaneous autoimmune responses to endogenous retrovirus antigens in NOD mice","volume":"47","author":"Bashratyan","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2025.114185_b0350","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2021.12.028","article-title":"SnapShot: Human endogenous retroviruses","volume":"185","author":"Jakobsson","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2025.114185_b0355","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7973165","article-title":"Cooccurrences of putative endogenous retrovirus-associated diseases","volume":"2017","author":"Br\u00fctting","year":"2017","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.intimp.2025.114185_b0360","doi-asserted-by":"crossref","first-page":"900","DOI":"10.2337\/diabetes.54.3.900","article-title":"Retrovirus-like long-terminal repeat DQ-LTR13 and genetic susceptibility to type 1 diabetes and autoimmune Addison's disease","volume":"54","author":"Gambelunghe","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2025.114185_b0365","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11892-017-0962-4","article-title":"Autoimmune responses to exosomes and candidate antigens contribute to type 1 diabetes in non-obese diabetic mice","volume":"17","author":"Dai","year":"2017","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.intimp.2025.114185_b0370","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.imlet.2020.04.007","article-title":"Endogenous retrovirus Gag antigen and its gene variants are unique autoantigens expressed in the pancreatic islets of non-obese diabetic mice","volume":"223","author":"Dai","year":"2020","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.intimp.2025.114185_b0375","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1210\/clinem\/dgad165","article-title":"COVID-19 as a trigger for type 1 diabetes","volume":"108","author":"Wang","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.intimp.2025.114185_b0380","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1053\/j.gastro.2022.01.018","article-title":"Treatment of type 1 diabetes by microbiome maintenance","volume":"162","author":"Strober","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2025.114185_b0385","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1007\/s00125-018-4704-1","article-title":"Unexpected subcellular distribution of a specific isoform of the Coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells","volume":"61","author":"Ifie","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.intimp.2025.114185_b0390","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s00125-017-4365-5","article-title":"Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: the TEDDY study","volume":"60","author":"L\u00f6nnrot","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.intimp.2025.114185_b0395","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1007\/s00125-018-4662-7","article-title":"Pandemic influenza and subsequent risk of type 1 diabetes: a nationwide cohort study","volume":"61","author":"Ruiz","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.intimp.2025.114185_b0400","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1001\/jama.2023.8674","article-title":"Type 1 diabetes incidence and risk in children with a diagnosis of COVID-19","volume":"329","author":"Weiss","year":"2023","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.intimp.2025.114185_b0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025792","article-title":"Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes","volume":"6","author":"Brown","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2025.114185_b0410","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40168-016-0163-4","article-title":"Towards a functional hypothesis relating anti-islet cell autoimmunity to the dietary impact on microbial communities and butyrate production","volume":"4","author":"Endesfelder","year":"2016","journal-title":"Microbiome."},{"key":"10.1016\/j.intimp.2025.114185_b0415","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01733","article-title":"Modulation of gut microbiota by low methoxyl pectin attenuates type 1 diabetes in non-obese diabetic mice","volume":"10","author":"Wu","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114185_b0420","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14628","article-title":"Daily experiences of type 1 diabetes stress across adulthood","volume":"39","author":"Kelly","year":"2022","journal-title":"Diabet. Med."},{"key":"10.1016\/j.intimp.2025.114185_b0425","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41366-023-01429-8","article-title":"The emergence of obesity in type 1 diabetes","volume":"48","author":"Kueh","year":"2024","journal-title":"Int. J. Obes. (Lond.)"},{"key":"10.1016\/j.intimp.2025.114185_b0430","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1902226","article-title":"An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2025.114185_b0435","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc8980","article-title":"Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals","volume":"13","author":"Sims","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2025.114185_b0440","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa2308743","article-title":"Teplizumab and \u03b2-cell function in newly diagnosed type 1 diabetes","volume":"389","author":"Ramos Eleanor","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2025.114185_b0445","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2337\/dc22-2200","article-title":"Abatacept for delay of type 1 diabetes progression in stage 1 relatives at risk: a randomized, double-masked","volume":"46","author":"Russell","year":"2023","journal-title":"Controlled Trial Diabetes Care"},{"key":"10.1016\/j.intimp.2025.114185_b0450","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2337\/db20-1103","article-title":"Low-dose ATG\/GCSF in established type 1 diabetes: a five-year follow-up report","volume":"70","author":"Lin","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2025.114185_b0455","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2337\/dc18-0494","article-title":"Low-dose anti-thymocyte globulin (ATG) preserves \u03b2-cell function and improves HbA1c in new-onset type 1 diabetes","author":"Haller","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.intimp.2025.114185_b0460","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2337\/dbi18-0058","article-title":"Function, failure, and the future potential of Tregs in type 1 diabetes","volume":"70","author":"Bettini","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2025.114185_b0465","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2025.114185_b0470","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","article-title":"T(reg) cell-based therapies: challenges and perspectives","volume":"20","author":"Raffin","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2025.114185_b0475","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.686439","article-title":"Precision engineering of an anti-HLA-A2 chimeric antigen receptor in regulatory T cells for transplant immune tolerance","volume":"12","author":"Muller","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114185_b0480","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jaut.2018.08.004","article-title":"Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II: peptide complex modulate the progression of autoimmune diabetes","volume":"96","author":"Zhang","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2025.114185_b0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111919","article-title":"PD-1 Receptor (+) T cells are associated with the efficacy of the combined treatment with regulatory t cells and rituximab in type 1 diabetes children via regulatory t cells suppressive activity amelioration","volume":"132","author":"Zieli\u0144ski","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.114185_b0490","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2219086120","article-title":"Tonic-signaling chimeric antigen receptors drive human regulatory T cell exhaustion","volume":"120","author":"Lamarche","year":"2023","journal-title":"PNAS"},{"key":"10.1016\/j.intimp.2025.114185_b0495","article-title":"Novel engineered B lymphocytes targeting islet-specific T cells inhibit the development of type 1 diabetes in non-obese diabetic Scid mice","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.114185_b0500","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.gt.3301746","article-title":"Constitutive and regulated expression of processed insulin following in vivo hepatic gene transfer","volume":"9","author":"Auricchio","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.intimp.2025.114185_b0505","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.gt.3301076","article-title":"Glucose regulated production of human insulin in rat hepatocytes","volume":"7","author":"Thul\u00e9","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/j.intimp.2025.114185_b0510","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2012.12","article-title":"Insulin gene therapy from design to beta cell generation","volume":"14","author":"Sanlioglu","year":"2012","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.intimp.2025.114185_b0515","first-page":"Fc01","article-title":"Red cell distribution width and serum BNP level correlation in diabetic patients with cardiac failure: a cross-sectional study","volume":"8","author":"Subhashree","year":"2014","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.intimp.2025.114185_b0520","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1210\/er.2018-00154","article-title":"Pancreatic islet transplantation in humans: recent progress and future directions","volume":"40","author":"Rickels","year":"2019","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.intimp.2025.114185_b0525","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.2337\/dc12-0063","article-title":"Improvement in outcomes of clinical islet transplantation: 1999-2010","volume":"35","author":"Barton","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.intimp.2025.114185_b0530","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0140-6736(19)31334-0","article-title":"Advances in \u03b2-cell replacement therapy for the treatment of type 1 diabetes","volume":"394","author":"Vantyghem","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2025.114185_b0535","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.2337\/dc15-1988","article-title":"Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia","volume":"39","author":"Hering","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.intimp.2025.114185_b0540","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/stcltm\/szac058","article-title":"Benefits and hurdles of pancreatic \u03b2-cell replacement","volume":"11","author":"Bolla","year":"2022","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.intimp.2025.114185_b0545","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.941918","article-title":"Editorial: first regulatory approval for allogeneic pancreatic islet beta cell infusion for adult patients with type 1 diabetes mellitus","volume":"29","author":"Parums","year":"2023","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.intimp.2025.114185_b0550","first-page":"402","article-title":"FDA greenlights first cell therapy for adults with type 1 diabetes","volume":"330","author":"Harris","year":"2023","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.intimp.2025.114185_b0555","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/S0140-6736(94)90570-3","article-title":"Transplantation of porcine fetal pancreas to diabetic patients","volume":"344","author":"Groth","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2025.114185_b0560","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/1753-0407.12395","article-title":"Current status and future of clinical islet xenotransplantation","volume":"8","author":"Matsumoto","year":"2016","journal-title":"J. Diabetes"},{"key":"10.1016\/j.intimp.2025.114185_b0565","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5500\/wjt.v5.i4.243","article-title":"Use of genetically-engineered pig donors in islet transplantation","volume":"5","author":"Bottino","year":"2015","journal-title":"World J. Transplant."},{"key":"10.1016\/j.intimp.2025.114185_b0570","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1111\/j.1600-6143.2011.03720.x","article-title":"Islet xenotransplantation using gal-deficient neonatal donors improves engraftment and function","volume":"11","author":"Thompson","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.intimp.2025.114185_b0575","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1111\/j.1600-6143.2009.02850.x","article-title":"Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets","volume":"9","author":"van der Windt","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.intimp.2025.114185_b0580","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1172\/JCI118649","article-title":"Large scale isolation, growth, and function of porcine neonatal islet cells","volume":"97","author":"Korbutt","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2025.114185_b0585","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.822191","article-title":"Multipotent mesenchymal stromal cells interact and support islet of Langerhans viability and function","volume":"13","author":"Koehler","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.intimp.2025.114185_b0590","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11892-017-0901-4","article-title":"Immunological issues after stem cell-based \u03b2 cell replacement","volume":"17","author":"Sordi","year":"2017","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.intimp.2025.114185_b0595","article-title":"Applications of iPSC-derived beta cells from patients with diabetes","volume":"2","author":"Maxwell","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.intimp.2025.114185_b0600","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.stemcr.2019.11.004","article-title":"Conformal coating of stem cell-derived islets for \u03b2 cell replacement in type 1 diabetes","volume":"14","author":"Stock","year":"2020","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.intimp.2025.114185_b0605","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/s41587-019-0227-7","article-title":"De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans","volume":"37","author":"Deuse","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.intimp.2025.114185_b0610","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/0140-6736(93)91148-F","article-title":"Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation","volume":"341","author":"Lampeter","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2025.114185_b0615","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/ajt.13216","article-title":"Development of autoimmune-mediated \u03b2 cell failure after total pancreatectomy with autologous islet transplantation","volume":"15","author":"Bellin","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.intimp.2025.114185_b0620","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.2337\/db12-1258","article-title":"Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetes","volume":"62","author":"Piemonti","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2025.114185_b0625","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.abh1657","article-title":"Strategies for durable \u03b2 cell replacement in type 1 diabetes","volume":"373","author":"Brusko","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.intimp.2025.114185_b0630","article-title":"From disease and patient heterogeneity to precision medicine in type 1 diabetes","volume":"9","author":"den Hollander","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.intimp.2025.114185_b0635","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2020.612377","article-title":"Early nutrition and risk of type 1 diabetes: the role of gut microbiota","volume":"7","author":"Verduci","year":"2020","journal-title":"Front. Nutr."},{"key":"10.1016\/j.intimp.2025.114185_b0640","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1056\/NEJMoa1004809","article-title":"Dietary intervention in infancy and later signs of beta-cell autoimmunity","volume":"363","author":"Knip","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2025.114185_b0645","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1001\/jama.2014.5610","article-title":"Hydrolyzed infant formula and early \u03b2-cell autoimmunity: a randomized clinical trial","volume":"311","author":"Knip","year":"2014","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.intimp.2025.114185_b0650","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-3083.1998.00282.x","article-title":"Cow milk feeding induces antibodies to insulin in children - a link between cow milk and insulin-dependent diabetes mellitus?","volume":"47","author":"Vaarala","year":"1998","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.intimp.2025.114185_b0655","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/apa.14756","article-title":"The jury is still out on possible links between cows\u2019 milk and type 1 diabetes","volume":"109","author":"Ludvigsson","year":"2020","journal-title":"Acta Paediat. Int. J. Paediat."},{"key":"10.1016\/j.intimp.2025.114185_b0660","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/ajcn\/78.6.1053","article-title":"Nutritional risk predictors of \u03b2 cell autoimmunity and type 1 diabetes at a young age","volume":"78","author":"Virtanen","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.intimp.2025.114185_b0665","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.fct.2018.12.015","article-title":"Skim milk powder with high content of Maillard reaction products affect weight gain, organ development and intestinal inflammation in early life in rats","volume":"125","author":"Hillman","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.intimp.2025.114185_b0670","doi-asserted-by":"crossref","DOI":"10.1038\/nutd.2017.16","article-title":"A1 beta-casein milk protein and other environmental pre-disposing factors for type 1 diabetes","volume":"7","author":"Chia","year":"2017","journal-title":"Nutr. Diabetes"},{"key":"10.1016\/j.intimp.2025.114185_b0675","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/jamapediatrics.2013.317","article-title":"Infant exposures and development of type 1 diabetes mellitus: The Diabetes Autoimmunity Study in the Young (DAISY)","volume":"167","author":"Frederiksen","year":"2013","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.intimp.2025.114185_b0680","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/aje\/kwx191","article-title":"Infant feeding in relation to the risk of advanced islet autoimmunity and type 1 diabetes in children with increased genetic susceptibility: a cohort study","volume":"187","author":"Hakola","year":"2018","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.intimp.2025.114185_b0685","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2337\/dc14-1130","article-title":"Infant feeding in relation to islet autoimmunity and type 1 diabetes in genetically susceptible children: the MIDIA study","volume":"38","author":"Lund-Blix","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.intimp.2025.114185_b0690","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1007\/s00125-006-0236-1","article-title":"Age at introduction of new foods and advanced beta cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes","volume":"49","author":"Virtanen","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.intimp.2025.114185_b0695","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2337\/dc18-2315","article-title":"Gluten intake and risk of islet autoimmunity and progression to type 1 diabetes in children at increased risk of the disease: The Diabetes autoimmunity study in the young (DAISY)","volume":"42","author":"Lund-Blix","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.intimp.2025.114185_b0700","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2337\/dc17-0016","article-title":"Infant feeding and risk of type 1 diabetes in two large Scandinavian birth cohorts","volume":"40","author":"Lund-Blix","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.intimp.2025.114185_b0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103633","article-title":"Dietary factors and risk of islet autoimmunity and type 1 diabetes: a systematic review and meta-analysis","volume":"72","author":"Lampousi","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.intimp.2025.114185_b0710","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0003-9861(03)00338-2","article-title":"Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus","volume":"417","author":"Zella","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.intimp.2025.114185_b0715","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.2337\/db13-1559","article-title":"Dietary supplementation with high doses of regular vitamin D3 safely reduces diabetes incidence in NOD mice when given early and long term","volume":"63","author":"Takiishi","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2025.114185_b0720","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/s41430-020-00813-1","article-title":"A dose\u2013response meta-analysis between serum concentration of 25-hydroxy vitamin D and risk of type 1 diabetes mellitus","volume":"75","author":"Hou","year":"2021","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.intimp.2025.114185_b0725","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.2337\/diacare.26.12.3237","article-title":"In utero dietary exposures and risk of islet autoimmunity in children","volume":"26","author":"Fronczak","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.intimp.2025.114185_b0730","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/S0140-6736(01)06580-1","article-title":"Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study","volume":"358","author":"Hypp\u00f6nen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2025.114185_b0735","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.tem.2005.06.004","article-title":"Vitamin D and type 1 diabetes mellitus: state of the art","volume":"16","author":"Mathieu","year":"2005","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.intimp.2025.114185_b0740","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4239\/wjd.v7.i9.177","article-title":"Positive evidence for vitamin A role in prevention of type 1 diabetes","volume":"7","author":"Yosaee","year":"2016","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.intimp.2025.114185_b0745","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.00125","article-title":"Evaluating the causal role of gut microbiota in type 1 diabetes and its possible pathogenic mechanisms","volume":"11","author":"Zhou","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.intimp.2025.114185_b0750","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/jamapediatrics.2015.2757","article-title":"Association of early exposure of probiotics and islet autoimmunity in the TEDDY study","volume":"170","author":"Uusitalo","year":"2016","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.intimp.2025.114185_b0755","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1007\/s00125-018-4738-4","article-title":"Probiotic intervention in infancy is not associated with development of beta cell autoimmunity and type 1 diabetes","volume":"61","author":"Savilahti","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.intimp.2025.114185_b0760","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1064185","article-title":"Exercise and nutrition in type 1 diabetes: Insights from the FinnDiane cohort","volume":"13","author":"Pongrac Barlovic","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925001754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925001754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T01:01:59Z","timestamp":1740618119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925001754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":152,"alternative-id":["S1567576925001754"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114185","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in the Pathogenesis and Treatment Strategies for Type 1 Diabetes Mellitus","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114185","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114185"}}